This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Ongoing energy price spikes tied to geopolitical tensions have shifted expectations for Federal Reserve policy. Trade...
Gold and silver slide in tandem as the XAG/XAU ratio tightens, signaling changing bets on safe-haven demand and indus...
Nokia’s stock rally fueled by AI and 6G optimism faces a potential pause as analysts urge profit-taking. Santander tr...
As AI investment expands across big-cap tech and startups, ACM Research and Ouster emerge as practical additions to s...
A leading XRP analyst lays out three bullish paths for XRP, each signaling multi-fold gains as crypto markets re-pric...
Kevin Warsh’s confirmation as Fed Chair ushers in a policy shift that could shape Bitcoin’s path. Here are five drive...
A Senate committee greenlit the CLARITY Act in a 15-9 vote, sending the bill to the full chamber. Markets jumped as X...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
A former Tesla president outlines a disciplined framework that helped scale Tesla during critical years, offering pra...
New York and New Jersey authorities have subpoenaed FIFA to probe ticketing practices for the 2026 World Cup at MetLi...
Groupon is charting a new path in local commerce as 2025 earnings loom. This guide breaks down the drivers, risks, an...